2022: a Pivotal Year for Diagnosis and Treatment of Rare Genetic Diseases
Overview
Authors
Affiliations
The start of 2022 is an inflection point in the development of diagnostics and treatments for rare genetic diseases in prenatal, pediatric, and adult individuals-the theme of this special issue. Here I briefly review recent developments in two pivotal aspects of genetic disease diagnostics and treatments: education and equitable implementation.
Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access.
Ellard S, Morgan S, Wynn S, Walker S, Parrish A, Mein R J Med Genet. 2024; 61(12):1103-1112.
PMID: 39327040 PMC: 11671936. DOI: 10.1136/jmg-2024-110228.
Parobek C, Zemet R, Shanahan M, Burnett B, Mizerik E, Rosenfeld J Clin Genet. 2024; 106(1):95-101.
PMID: 38545656 PMC: 11147704. DOI: 10.1111/cge.14522.
Perolla A, Calliku E, Cili A, Caja T, Pulluqi P, Ivanaj A Cureus. 2024; 16(1):e52091.
PMID: 38222997 PMC: 10784772. DOI: 10.7759/cureus.52091.
Pande S, Majethia P, Nair K, Rao L, Mascarenhas S, Kaur N Eur J Hum Genet. 2023; 32(10):1291-1298.
PMID: 38114583 PMC: 7616498. DOI: 10.1038/s41431-023-01513-7.
A rapid whole-genome sequencing service for infants with rare diseases in the United Arab Emirates.
Abou Tayoun A, Alsheikh-Ali A Nat Med. 2023; 29(12):2979-2980.
PMID: 37872224 DOI: 10.1038/s41591-023-02596-x.